Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 309

1.

Development, usability and acceptability of an integrated eHealth system for spondyloarthritis in the Netherlands (SpA-Net).

Webers C, Beckers E, Boonen A, van Eijk-Hustings Y, Vonkeman H, van de Laar M, van Tubergen A.

RMD Open. 2019 Apr 11;5(1):e000860. doi: 10.1136/rmdopen-2018-000860. eCollection 2019.

2.

A comparative study of real-life management strategies in gout: data from two protocolized gout clinics.

Te Kampe R, van Durme C, Janssen M, van Eijk-Hustings Y, Boonen A, Jansen TL.

Arthritis Care Res (Hoboken). 2019 May 31. doi: 10.1002/acr.23995. [Epub ahead of print]

PMID:
31150161
3.

Considerations for Evaluating and Recommending Worker Productivity Outcome Measures: An Update from the OMERACT Worker Productivity Group.

Verstappen SMM, Lacaille D, Boonen A, Escorpizo R, Hofstetter C, Bosworth A, Leong A, Leggett S, Gignac MAM, Wallman JK, Terwee MM, Berghea F, Agaliotis M, Tugwell P, Beaton D.

J Rheumatol. 2019 Apr 1. pii: jrheum.181201. doi: 10.3899/jrheum.181201. [Epub ahead of print]

PMID:
30936275
4.

Workforce requirements in rheumatology: a systematic literature review informing the development of a workforce prediction risk of bias tool and the EULAR points to consider.

Unger J, Putrik P, Buttgereit F, Aletaha D, Bianchi G, Bijlsma JWJ, Boonen A, Cikes N, Dias JM, Falzon L, Finckh A, Gossec L, Kvien TK, Matteson EL, Sivera F, Stamm TA, Szekanecz Z, Wiek D, Zink A, Dejaco C, Ramiro S.

RMD Open. 2018 Dec 5;4(2):e000756. doi: 10.1136/rmdopen-2018-000756. eCollection 2018.

5.

EULAR 'points to consider' for the conduction of workforce requirement studies in rheumatology.

Dejaco C, Putrik P, Unger J, Aletaha D, Bianchi G, Bijlsma JW, Boonen A, Cikes N, Finckh A, Gossec L, Kvien TK, Madruga Dias J, Matteson EL, Sivera F, Stamm TA, Szekanecz Z, Wiek D, Zink A, Ramiro S, Buttgereit F.

RMD Open. 2018 Dec 5;4(2):e000780. doi: 10.1136/rmdopen-2018-000780. eCollection 2018.

6.

OMERACT Development of a Core Domain Set of Outcomes for Shared Decision-making Interventions.

Toupin-April K, Barton JL, Fraenkel L, Meara A, Li LC, Brooks P, de Wit M, Stacey D, Légaré F, Shea B, Lyddiatt A, Hofstetter C, Christensen R, Scholte Voshaar M, Suarez-Almazor ME, Boonen A, Meade T, March L, Jull JE, Campbell W, Alten R, Karuranga S, Morgan EM, Kelly A, Kaufman J, Hill S, Maxwell LJ, Beaton D, El-Miedany Y, Mittoo S, Bartlett SJ, Singh JA, Tugwell PS.

J Rheumatol. 2019 Feb 1. pii: jrheum.181071. doi: 10.3899/jrheum.181071. [Epub ahead of print]

PMID:
30709963
7.

Updating OMERACT Core Set of Domains for ANCA-associated Vasculitis: Patient Perspective Using the International Classification of Function, Disability, and Health.

Milman N, McConville E, Robson JC, Boonen A, Tugwell P, Wells GA, Chaudhuri D, Dawson J, Tomasson G, Ashdown S, Gebhart D, Lanier G, Peck J, McAlear CA, Kellom KS, Cronholm PF, Merkel PA.

J Rheumatol. 2019 Feb 1. pii: jrheum.181073. doi: 10.3899/jrheum.181073. [Epub ahead of print]

PMID:
30709951
8.

Impact of the definition of osteoarthritis and of the timing of its onset on the association between type 2 diabetes mellitus and osteoarthritis: Clinical Practice Research Datalink.

Nielen JTH, Dagnelie PC, Boonen A, Klungel O, van den Bemt B, de Vries F.

Diabetes Res Clin Pract. 2019 Feb;148:240-248. doi: 10.1016/j.diabres.2019.01.021. Epub 2019 Jan 24.

PMID:
30685347
9.

Individual-level and country-level socioeconomic determinants of disease outcomes in SpA: multinational, cross-sectional study (ASAS-COMOSPA).

Putrik P, Ramiro S, Moltó A, Keszei AP, Norton S, Dougados M, van der Heijde D, Landewé RBM, Boonen A.

Ann Rheum Dis. 2019 Apr;78(4):486-493. doi: 10.1136/annrheumdis-2018-214259. Epub 2019 Jan 23.

PMID:
30674477
10.

Identifying Provisional Generic Contextual Factor Domains for Clinical Trials in Rheumatology: Results from an OMERACT Initiative.

Nielsen SM, Tugwell P, de Wit MPT, Boers M, Beaton DE, Woodworth TG, Escorpizo R, Shea B, Toupin-April K, Guillemin F, Strand V, Singh JA, Kloppenburg M, Furst DE, Wells GA, Smolen JS, Veselý R, Boonen A, Storgaard H, Voshaar M, March L, Christensen R; Contextual Factors Working Group.

J Rheumatol. 2019 Jan 15. pii: jrheum.181081. doi: 10.3899/jrheum.181081. [Epub ahead of print]

PMID:
30647174
11.

Geriatric syndromes in patients with rheumatoid arthritis: a literature overview.

Cleutjens FAHM, Boonen AERCH, van Onna MGB.

Clin Exp Rheumatol. 2019 May-Jun;37(3):496-501. Epub 2018 Dec 19. Review.

PMID:
30620280
12.

Sick leave and its predictors in ankylosing spondylitis: long-term results from the Outcome in Ankylosing Spondylitis International Study.

Webers C, Ramiro S, Landewé R, van der Heijde D, van den Bosch F, Dougados M, van Tubergen A, Boonen A.

RMD Open. 2018 Nov 27;4(2):e000766. doi: 10.1136/rmdopen-2018-000766. eCollection 2018.

13.

Uncovering the heterogeneity of disease impact in axial spondyloarthritis: bivariate trajectories of disease activity and quality of life.

Imkamp M, Lima Passos V, Boonen A, Arends S, Dougados M, Landewé R, Ramiro S, Van den Bosch F, van der Heijde D, Wink FR, Spoorenberg A, van Tubergen A.

RMD Open. 2018 Nov 14;4(2):e000755. doi: 10.1136/rmdopen-2018-000755. eCollection 2018.

14.

The International Consortium for Health Outcome Measurement (ICHOM)Set of Outcomes that Matter to People Living with Inflammatory Arthritis Consensus from an international Working Group.

Oude Voshaar MAH, Das Gupta Z, Bijlsma JWJ, Boonen A, Chau J, Courvoisier DS, Curtis JR, Ellis B, Ernestam S, Gossec L, Hale C, Hornjeff J, Leung KYY, Lidar M, Mease P, Michaud K, Mody GM, Ndosi M, Opava CH, Pinheiro GRC, Salt M, Soriano ER, Taylor WJ, Voshaar MJH, Weel AEAM, de Wit M, Wulffraat N, van de Laar MAFJ, Vonkeman HE.

Arthritis Care Res (Hoboken). 2018 Oct 24. doi: 10.1002/acr.23799. [Epub ahead of print]

PMID:
30358135
15.

Conceptual model for the health technology assessment of current and novel interventions in rheumatoid arthritis.

Alemao E, Al MJ, Boonen AA, Stevenson MD, Verstappen SMM, Michaud K, Weinblatt ME, Rutten-van Mölken MPMH.

PLoS One. 2018 Oct 5;13(10):e0205013. doi: 10.1371/journal.pone.0205013. eCollection 2018.

16.

Consumption of dairy products in relation to the presence of clinical knee osteoarthritis: The Maastricht Study.

Denissen KFM, Boonen A, Nielen JTH, Feitsma AL, van den Heuvel EGHM, Emans PJ, Stehouwer CDA, Sep SJS, van Dongen MCJM, Dagnelie PC, Eussen SJPM.

Eur J Nutr. 2018 Sep 21. doi: 10.1007/s00394-018-1818-7. [Epub ahead of print]

PMID:
30242468
17.

Secular trends in major osteoporotic fractures among 50+ adults in Denmark between 1995 and 2010.

Abtahi S, Driessen JHM, Vestergaard P, van den Bergh J, Boonen A, de Vries F, Burden AM.

Arch Osteoporos. 2018 Aug 27;13(1):91. doi: 10.1007/s11657-018-0503-z.

18.

Performance of the Michigan Hand Outcomes Questionnaire in hand osteoarthritis.

Kroon FPB, Boersma A, Boonen A, van Beest S, Damman W, van der Heijde D, Rosendaal FR, Kloppenburg M.

Osteoarthritis Cartilage. 2018 Dec;26(12):1627-1635. doi: 10.1016/j.joca.2018.07.018. Epub 2018 Aug 9.

PMID:
30099114
19.

Employment and the role of personal factors among patients with ankylosing spondylitis: a Dutch cross-sectional case-control study.

Webers C, Vanhoof L, van Genderen S, Heuft L, van de Laar M, Luime J, van der Heijde D, van Gaalen FA, Spoorenberg A, Boonen A.

RMD Open. 2018 Jun 27;4(1):e000680. doi: 10.1136/rmdopen-2018-000680. eCollection 2018.

20.

Socio-economic gradients in the presence of musculoskeletal and other chronic diseases: results from a cross-sectional study in the Netherlands.

Putrik P, Ramiro S, Chorus AM, Keszei AP, Boonen A.

Clin Rheumatol. 2018 Dec;37(12):3173-3182. doi: 10.1007/s10067-018-4158-3. Epub 2018 Jun 12.

PMID:
29948350
21.

Disease and management beliefs of elderly patients with rheumatoid arthritis and comorbidity: a qualitative study.

van Onna M, Öztürk B, Starmans M, Peeters R, Boonen A.

Clin Rheumatol. 2018 Sep;37(9):2367-2372. doi: 10.1007/s10067-018-4167-2. Epub 2018 Jun 9.

22.

Medication adherence among gout patients initiated allopurinol: a retrospective cohort study in the Clinical Practice Research Datalink (CPRD).

Scheepers LEJM, Burden AM, Arts ICW, Spaetgens B, Souverein P, de Vries F, Boonen A.

Rheumatology (Oxford). 2018 Sep 1;57(9):1641-1650. doi: 10.1093/rheumatology/key155.

PMID:
29893941
23.

Work participation in spondyloarthritis across countries: analysis from the ASAS-COMOSPA study.

Rodrigues Manica S, Sepriano A, Ramiro S, Pimentel Santos F, Putrik P, Nikiphorou E, Norton S, Molto A, Dougados M, van der Heijde D, Landewé RBM, van den Bosch FE, Boonen A.

Ann Rheum Dis. 2018 Sep;77(9):1303-1310. doi: 10.1136/annrheumdis-2018-213464. Epub 2018 Jun 2.

PMID:
29860232
24.

Measurement properties of the ASAS Health Index: results of a global study in patients with axial and peripheral spondyloarthritis.

Kiltz U, van der Heijde D, Boonen A, Akkoc N, Bautista-Molano W, Burgos-Vargas R, Wei JC, Chiowchanwisawakit P, Dougados M, Duruoz MT, Elzorkany BK, Gaydukova I, Gensler LS, Gilio M, Grazio S, Gu J, Inman RD, Kim TJ, Navarro-Compan V, Marzo-Ortega H, Ozgocmen S, Pimentel Dos Santos F, Schirmer M, Stebbings S, Van den Bosch FE, van Tubergen A, Braun J.

Ann Rheum Dis. 2018 Sep;77(9):1311-1317. doi: 10.1136/annrheumdis-2017-212076. Epub 2018 Jun 1.

25.

The Association Between β-Blocker Use and Cardiorespiratory Fitness: The Maastricht Study.

Nielen JTH, de Vries F, van der Velde JHPM, Savelberg HHCM, Schaper NC, Dagnelie PC, Henry RMA, Schram M, Stehouwer CDA, Boonen A, Koster A, van den Bemt BJF.

J Cardiovasc Pharmacol Ther. 2019 Jan;24(1):37-45. doi: 10.1177/1074248418778551. Epub 2018 May 24.

26.

Are globals for health, well-being and quality of life interchangeable? A mixed methods study in ankylosing spondylitis patients and controls.

van Tubergen A, Gulpen A, Landewé R, Boonen A.

Rheumatology (Oxford). 2018 Sep 1;57(9):1555-1562. doi: 10.1093/rheumatology/key129.

PMID:
29788458
27.

An Economic Evaluation of Stopping Versus Continuing Tumor Necrosis Factor Inhibitor Treatment in Rheumatoid Arthritis Patients With Disease Remission or Low Disease Activity: Results From a Pragmatic Open-Label Trial.

Tran-Duy A, Ghiti Moghadam M, Oude Voshaar MAH, Vonkeman HE, Boonen A, Clarke P, McColl G, Ten Klooster PM, Zijlstra TR, Lems WF, Riyazi N, Griep EN, Hazes JMW, Landewé R, Bernelot Moens HJ, van Riel PLCM, van de Laar MAFJ, Jansen TL; Dutch National POET Collaboration.

Arthritis Rheumatol. 2018 Oct;70(10):1557-1564. doi: 10.1002/art.40546. Epub 2018 Aug 23.

PMID:
29745059
28.

Socio-economic inequalities in occurrence and health care costs in rheumatic and musculoskeletal diseases: results from a Spanish population-based study including 1.9 million persons.

Putrik P, Ramiro S, Orueta JF, Keszei A, Alonso Moran E, Nuño Solinis R, Boonen A.

Clin Exp Rheumatol. 2018 Jul-Aug;36(4):589-594. Epub 2018 Jan 31.

29.

Rheumatologists' Views and Experiences in Managing Rheumatoid Arthritis in Elderly Patients: A Qualitative Study.

Nawrot J, Boonen A, Peeters R, Starmans M, van Onna M.

J Rheumatol. 2018 May;45(5):590-594. doi: 10.3899/jrheum.170773. Epub 2018 Feb 15.

PMID:
29449497
30.

Association of type 2 diabetes mellitus with self-reported knee pain and clinical knee osteoarthritis: The Maastricht Study.

Nielen JTH, Emans PJ, van den Bemt B, Dagnelie PC, Schram MT, Stehouwer CDA, Schaper NC, Denissen KFM, de Vries F, Boonen A.

Diabetes Metab. 2018 Jun;44(3):296-299. doi: 10.1016/j.diabet.2018.01.013. Epub 2018 Feb 3. No abstract available.

PMID:
29422359
31.

Contextual factors influence work outcomes in employed patients with ankylosing spondylitis starting etanercept: 2-year results from AS@Work.

Boonen A, Boone C, Albert A, Mielants H.

Rheumatology (Oxford). 2018 May 1;57(5):791-797. doi: 10.1093/rheumatology/kex476.

PMID:
29373701
32.

The eumusc.net standards of care for rheumatoid arthritis: importance and current implementation according to patients and healthcare providers in the Netherlands.

Hifinger M, Ramiro S, Putrik P, van Eijk-Hustings Y, Woolf A, Smolen JS, Stoffer-Marx M, Uhlig T, Moe RH, Saritas M, Janson M, van der Helm-van Mil A, van de Laar M, Vonkeman H, de Wit M, Boonen A.

Clin Exp Rheumatol. 2018 Mar-Apr;36(2):275-283. Epub 2017 Dec 15.

PMID:
29303700
33.

Deriving common comorbidity indices from the MedDRA classification and exploring their performance on key outcomes in patients with rheumatoid arthritis.

Putrik P, Ramiro S, Lie E, Michaud K, Kvamme MK, Keszei AP, Kvien TK, Uhlig T, Boonen A.

Rheumatology (Oxford). 2018 Mar 1;57(3):548-554. doi: 10.1093/rheumatology/kex440.

PMID:
29272517
35.

Disease burden of knee osteoarthritis patients with a joint replacement compared to matched controls: a population-based analysis of a Dutch medical claims database.

Nielen JTH, Boonen A, Dagnelie PC, van den Bemt BJF, Emans PJ, Lafeber FPJG, van Spil WE, de Vries F, Welsing PMJ.

Osteoarthritis Cartilage. 2018 Feb;26(2):202-210. doi: 10.1016/j.joca.2017.11.012. Epub 2017 Dec 2.

36.

Medication adherence among patients with gout: A systematic review and meta-analysis.

Scheepers LEJM, van Onna M, Stehouwer CDA, Singh JA, Arts ICW, Boonen A.

Semin Arthritis Rheum. 2018 Apr;47(5):689-702. doi: 10.1016/j.semarthrit.2017.09.007. Epub 2017 Oct 7. Review.

PMID:
29198878
37.

Comment on: Patients' preferences for anti-osteoporosis drug treatment: a cross-European discrete choice experiment: reply.

Hiligsmann M, Dellaert BG, Watson V, Boonen A.

Rheumatology (Oxford). 2018 Mar 1;57(3):584-585. doi: 10.1093/rheumatology/kex430. No abstract available.

PMID:
29194497
38.

Large country differences in work outcomes in patients with RA - an analysis in the multinational study COMORA.

van der Zee-Neuen A, Putrik P, Ramiro S, Keszei AP, Hmamouchi I, Dougados M, Boonen A.

Arthritis Res Ther. 2017 Sep 29;19(1):216. doi: 10.1186/s13075-017-1421-y.

39.

Influence of disease activity on RA treatment choices in countries with restricted access to expensive, innovative drugs: a discrete choice experiment among rheumatologists.

Hifinger M, Hiligsmann M, Ramiro S, Watson V, Berghea F, Péntek M, Keat A, Severens JL, Fautrel B, Boonen A.

RMD Open. 2017 Sep 4;3(2):e000453. doi: 10.1136/rmdopen-2017-000453. eCollection 2017.

40.

Equivalence in the Health Assessment Questionnaire (HAQ) across socio-demographic determinants: Analyses within QUEST-RA.

Hifinger M, Norton S, Ramiro S, Putrik P, Sokka-Isler T, Boonen A.

Semin Arthritis Rheum. 2018 Feb;47(4):492-500. doi: 10.1016/j.semarthrit.2017.08.003. Epub 2017 Aug 9.

PMID:
28893409
41.

OMERACT Endorsement of Patient-reported Outcome Instruments in Antineutrophil Cytoplasmic Antibody-associated Vasculitis.

Robson JC, Tomasson G, Milman N, Ashdown S, Boonen A, Casey GC, Cronholm PF, Cuthbertson D, Dawson J, Direskeneli H, Easley E, Kermani TA, Farrar JT, Gebhart D, Lanier G, Luqmani RA, Mahr A, McAlear CA, Peck J, Shea B, Shea JA, Sreih AG, Tugwell PS, Merkel PA.

J Rheumatol. 2017 Oct;44(10):1529-1535. doi: 10.3899/jrheum.161139. Epub 2017 Sep 1.

42.

Toward the Development of a Core Set of Outcome Domains to Assess Shared Decision-making Interventions in Rheumatology: Results from an OMERACT Delphi Survey and Consensus Meeting.

Toupin-April K, Barton J, Fraenkel L, Li LC, Brooks P, De Wit M, Stacey D, Légaré F, Meara A, Shea B, Lyddiatt A, Hofstetter C, Gossec L, Christensen R, Scholte-Voshaar M, Suarez-Almazor ME, Boonen A, Meade T, March L, Pohl C, Jull JE, Sivarajah S, Campbell W, Alten R, Karuranga S, Morgan E, Kaufman J, Hill S, Maxwell LJ, Welch V, Beaton D, El-Miedany Y, Tugwell PS.

J Rheumatol. 2017 Oct;44(10):1544-1550. doi: 10.3899/jrheum.161241. Epub 2017 Aug 1.

43.

Telemedicine for management of inflammatory bowel disease (myIBDcoach): a pragmatic, multicentre, randomised controlled trial.

de Jong MJ, van der Meulen-de Jong AE, Romberg-Camps MJ, Becx MC, Maljaars JP, Cilissen M, van Bodegraven AA, Mahmmod N, Markus T, Hameeteman WM, Dijkstra G, Masclee AA, Boonen A, Winkens B, van Tubergen A, Jonkers DM, Pierik MJ.

Lancet. 2017 Sep 2;390(10098):959-968. doi: 10.1016/S0140-6736(17)31327-2. Epub 2017 Jul 14.

PMID:
28716313
44.
45.

Social Role Participation and Satisfaction With Life: A Study Among Patients With Ankylosing Spondylitis and Population Controls.

van Genderen S, Plasqui G, van der Heijde D, van Gaalen F, Heuft L, Luime J, Spoorenberg A, Arends S, Lacaille D, Gignac M, Landewé R, Boonen A.

Arthritis Care Res (Hoboken). 2018 Apr;70(4):600-607. doi: 10.1002/acr.23304. Epub 2018 Feb 18.

46.

Valuing Treatment With Infliximab for Ankylosing Spondylitis Using a Willingness-to-Pay Approach.

Webers C, Essers I, van Tubergen A, Braun J, Heldmann F, Baraliakos X, Boonen A.

Arthritis Care Res (Hoboken). 2018 Apr;70(4):608-616. doi: 10.1002/acr.23299. Epub 2018 Feb 18.

47.

Uric acid and blood pressure: exploring the role of uric acid production in The Maastricht Study.

Scheepers LEJM, Boonen A, Dagnelie PC, Schram MT, van der Kallen CJH, Henry RMA, Kroon AA, Stehouwer CDA, Arts ICW.

J Hypertens. 2017 Oct;35(10):1968-1975. doi: 10.1097/HJH.0000000000001417.

PMID:
28520613
48.

Risk of infections in patients with gout: a population-based cohort study.

Spaetgens B, de Vries F, Driessen JHM, Leufkens HG, Souverein PC, Boonen A, van der Meer JWM, Joosten LAB.

Sci Rep. 2017 May 3;7(1):1429. doi: 10.1038/s41598-017-01588-5.

49.

An OMERACT Initiative Toward Consensus to Identify and Characterize Candidate Contextual Factors: Report from the Contextual Factors Working Group.

Finger ME, Boonen A, Woodworth TG, Escorpizo R, Christensen R, Nielsen SM, Leong AL, Scholte Voshaar M, Flurey CA, Milman N, Verstappen SM, Alten R, Guillemin F, Kloppenburg M, Beaton DE, Tugwell PS, March LM, Furst DE, Pohl C.

J Rheumatol. 2017 Nov;44(11):1734-1739. doi: 10.3899/jrheum.161200. Epub 2017 May 1.

PMID:
28461648
50.

Patients' preferences for anti-osteoporosis drug treatment: a cross-European discrete choice experiment.

Hiligsmann M, Dellaert BG, Dirksen CD, Watson V, Bours S, Goemaere S, Reginster JY, Roux C, McGowan B, Silke C, Whelan B, Diez-Perez A, Torres E, Papadakis G, Rizzoli R, Cooper C, Pearson G, Boonen A.

Rheumatology (Oxford). 2017 Jul 1;56(7):1167-1176. doi: 10.1093/rheumatology/kex071.

Supplemental Content

Loading ...
Support Center